The only “news” I saw was a PR that they will hold an investors’ presentation in October. Did I miss something?
By the way, the more I hear of SPPI, the less I like. I think they have grossly misstated the nature of their relationship with GPCB for Satraplatin, and that doesn’t make me feel good about their management.
Market Data 
Markets 
AI
